ARTICLE | Distillery Therapeutics
Cancer
September 11, 2017 7:31 PM UTC
Mouse studies suggest inhibiting NELFB could help treat BRCA1-deficient breast cancer. In a mouse model of BRCA1 knockout-induced breast cancer, co-knockout of NELFB increased the number of tumor-free...
BCIQ Company Profiles